References
- Wallingford JB, Niswander LA, Shaw GM, et al. The continuing challenge of understanding, preventing, and treating neural tube defects. Science. 2013;339(6123):1222002.
- Dias MS, Partington M. Embryology of myelomeningocele and anencephaly. FOC. 2004;16(2):1–16.
- Zaganjor I, Sekkarie A, Tsang BL, et al. Describing the prevalence of neural tube defects worldwide: a systematic literature review. PLOS One. 2016;11(4):e0151586
- Godbole K, Deshmukh U, Yajnik C. Nutrigenetic determinants of neural tube defects in India. Indian Pediatr. 2009;46(6):467–475.
- Verma IC. Burden of genetic disorders in India. Indian J Pediatr. 2000;67(12):893–898.
- Frey L, Hauser WA. Epidemiology of neural tube defects. Epilepsia. 2003;44(Suppl 3):4–13.
- De-Regil LM, Fernández-Gaxiola AC, Dowswell T, et al. Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2010;10(10):CD007950.
- Greene NDE, Stanier P, Copp AJ. Genetics of human neural tube defects. Hum Mol Genet. 2009;18(R2):R113–R129.
- Relton CL, Wilding CS, Pearce MS, et al. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet. 2004;41(4):256–260.
- Guideline: Daily iron and folic acid supplementation in pregnant women. Geneva: World Health Organization; 2012. [archived]. http://www.who.int/nutrition/publications/micronutrients/guidelines/daily_ifa_supp_pregnant_women/en/
- De-Regil LM, Peña-Rosas JP, Fernández-Gaxiola AC, et al. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2015;12(12):CD007950.
- Parker SE, Yazdy MM, Tinker SC, et al. The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida. Am J Obstet Gynecol. 2013; 209(3):239.e1–239.e8.
- Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol. 2000;151(9):862–877.
- Chen CP. Syndromes, disorders and maternal risk factors associated with neural tube defects (I). Taiwan J Obstet Gynecol. 2008;47(1):1–9.
- Chen CP. Chromosomal abnormalities associated with neural tube defects (II): partial aneuploidy. Taiwan J Obstet Gynecol. 2007;46(4):336–351.
- Mitchell LE. Epidemiology of neural tube defects. Am J Med Genet C Semin Med Genet. 2005;135C(1):88–94.
- Rai SK, Singh R, Pandey S, et al. High incidence of neural tube defects in Northern part of India. Asian J Neurosurg. 2016;11(4):352–355.
- Copp AJ, Greene ND. Genetics and development of neural tube defects. J Pathol. 2010;220(2):217–230.
- World Health Organization. Global health estimates (GHE)–Cause-specific mortality. 2015. [cited 2015 Apr 14]. Available from http://www.who.int/healthinfo/globalburdendisease/estimates/en/index1.html.
- Wilson RD, Prenatal screening, diagnosis, and pregnancy management of fetal neural tube defects. J Obstet Gynaecol Can. 2014;36(10):927–939.
- Airede IK. Neural tube defects in the middle belt of Nigeria. J Trop Pediatr. 1992;38(1):27–29.
- Chand MB, Agrawal J, Dr, Bista P. Anaesthetic challenges and management of myelomeningocele repair. Postgraduate Medical Journal of NAMS. 2011;11(1):41–46.
- Ntimbani J, Kelly A, Lekgwara P. Myelomeningocele – a literature review. Interdisciplinary Neurosurgery. 2020;19:100502.
- Northrup H, Volcik KA. Spina bifida and other neural tube defects. Curr Probl Pediatr. 2000;30(10):313–332.
- Oncel MY, Ozdemir R, Kahilogulları G, et al. The effect of surgery time on prognosis in newborns with meningomyelocele. J Korean Neurosurg Soc. 2012;51(6):359–362.
- McDowell MM, Lee PS, Foster KA, et al. The use of external ventricular drainage to reduce the frequency of wound complications in myelomeningocele closure. Pediatr Neurosurg. 2018;53(2):100–107.
- Anegbe AO, Shokunbi MT, Oyemolade TA, et al. Intracranial infection in patients with myelomeningocele: profile and risk factors. Childs Nerv Syst. 2019;35(11):2205–2210.